We are live on ! Find out more
SA

Sovran Advisors Portfolio holdings

AUM $1.34B
1-Year Est. Return 21.63%
This Fund
S&P 500
This Quarter Est. Return
+1.28%
1 Year Est. Return
+21.63%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.18B
AUM Growth
+$45.3M
Cap. Flow
+$31.6M
Cap. Flow %
2.69%
Top 10 Hldgs %
18.09%
Holding
582
New
63
Increased
234
Reduced
235
Closed
31

Sector Composition

Rank Sector Weight
1 Technology 11.45%
2 Financials 4.01%
3 Communication Services 3.03%
4 Consumer Discretionary 2.65%
5 Healthcare 2.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RTX icon
226
RTX Corp
RTX
$283B
$1.03M 0.09%
5,168
+24
+0.5% +$4.17K
SPHQ icon
227
Invesco S&P 500 Quality ETF
SPHQ
$19.7B
$1.02M 0.09%
13,116
+2,693
+26% +$200K
ADBE icon
228
Adobe
ADBE
$108B
$1.01M 0.09%
3,337
-79
-2% -$26.9K
FSK icon
229
FS KKR Capital
FSK
$3.32B
$1.01M 0.09%
68,674
-955
-1% -$14.5K
SCHX icon
230
Schwab US Large- Cap ETF
SCHX
$74B
$1M 0.09%
36,550
-7,611
-17% -$203K
BFRZ
231
Innovator Equity Managed 100 Buffer ETF
BFRZ
$142M
$998K 0.08%
36,935
-416
-1% -$11.1K
VIOG icon
232
Vanguard S&P Small-Cap 600 Growth ETF
VIOG
$1.1B
$998K 0.08%
7,703
+355
+5% +$43.2K
FLRG icon
233
Fidelity US Multifactor ETF
FLRG
$297M
$995K 0.08%
25,937
+1,137
+5% +$43.3K
XLF icon
234
State Street Financial Select Sector SPDR ETF
XLF
$56.9B
$986K 0.08%
18,135
-1,464
-7% -$78K
COWZ icon
235
Pacer US Cash Cows 100 ETF
COWZ
$20.1B
$986K 0.08%
15,831
-4,134
-21% -$243K
VGSH icon
236
Vanguard Short-Term Treasury ETF
VGSH
$30.3B
$981K 0.08%
16,709
+626
+4% +$36.8K
IYH icon
237
iShares US Healthcare ETF
IYH
$3.84B
$969K 0.08%
14,692
+176
+1% +$11.1K
EMB icon
238
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
$967K 0.08%
10,029
+1,319
+15% +$127K
VWO icon
239
Vanguard FTSE Emerging Markets ETF
VWO
$126B
$964K 0.08%
17,116
+1,240
+8% +$67.4K
JEPI icon
240
JPMorgan Equity Premium Income ETF
JEPI
$46.5B
$962K 0.08%
16,469
-28,172
-63% -$1.61M
XSMO icon
241
Invesco S&P SmallCap Momentum ETF
XSMO
$3B
$962K 0.08%
12,420
+503
+4% +$36.6K
BNY
242
Bank of New York Mellon
BNY
$111B
$958K 0.08%
7,727
-889
-10% -$98.4K
PAVE icon
243
Global X US Infrastructure Development ETF
PAVE
$13.7B
$955K 0.08%
18,576
-43,092
-70% -$2.07M
VYM icon
244
Vanguard High Dividend Yield ETF
VYM
$83.2B
$947K 0.08%
6,368
-124
-2% -$17.6K
IFRA icon
245
iShares US Infrastructure ETF
IFRA
$4.23B
$943K 0.08%
16,666
+211
+1% +$11.2K
RSP icon
246
Invesco S&P 500 Equal Weight ETF
RSP
$100B
$941K 0.08%
4,717
+1,229
+35% +$233K
AKRE
247
Akre Focus ETF
AKRE
$5.46B
$939K 0.08%
+14,811
New +$959K
BE icon
248
Bloom Energy
BE
$63.8B
$934K 0.08%
6,714
+45
+0.7% +$4.73K
IDU icon
249
iShares US Utilities ETF
IDU
$1.33B
$932K 0.08%
8,422
+253
+3% +$28.3K
MCD icon
250
McDonald's
MCD
$190B
$932K 0.08%
3,019
+107
+4% +$32.8K

Similar funds

Sovran Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, Sovran Advisors held 582 positions worth $1.18B, up 4% from $1.13B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Sovran Advisors's Q4 2025 filing shows 63 new, 234 increased, 235 reduced and 31 closed positions. Its largest new stake was CoreWeave: 70,438 shares worth $6.69M. The largest sale was Ionis Pharmaceuticals, an estimated $11.2M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Communication Services.

  • Sovran Advisors's largest Q4 2025 buy was CoreWeave: 70,438 shares worth $6.69M.
  • Sovran Advisors added most to Broadcom in Q4 2025, an estimated $6M increase.
  • Sovran Advisors's biggest Q4 2025 reduction was PIMCO RAFI Multi-Factor International Equity ETF, cutting an estimated $4.07M.
  • Sovran Advisors fully exited Ionis Pharmaceuticals in Q4 2025, selling an estimated $11.2M.
  • Sovran Advisors's ten largest holdings make up 18% of its $1.18B portfolio in Q4 2025.
  • Sovran Advisors opened 63 new positions and closed 31 in Q4 2025.
  • Sovran Advisors's portfolio value rose 4% quarter-over-quarter to $1.18B.

Based on Sovran Advisors's 13F filing for Q4 2025, filed 20 Jan 2026.